cd8a apcvio770 (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
95
Structured Review
Miltenyi Biotec
cd8a apcvio770
Cd8a Apcvio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 269 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8a+apcvio770/CD8+Antibody%2C+anti-human%2C+APC-Vio+770%2C+REAfinity/pm40374689-266-52-55
Average 95 stars, based on 269 article reviews
Cd8a Apcvio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 269 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8a+apcvio770/CD8+Antibody%2C+anti-human%2C+APC-Vio+770%2C+REAfinity/pm40374689-266-52-55
Average 95 stars, based on 269 article reviews
cd8a apcvio770 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Concentration Assay:Article Title: MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension. Article Snippet: Mitogen-activated protein kinases (MAPKs) require MAPK phosphatases (MKPs) for deactivation of MAPK intracellular signaling.. MKP-1 (encoded by Dusp1) is a key negative regulator of MAPKs and prior reports have indicated that MKP-1 regulates oral cancer-associated inflammation and leukocyte infiltration.. Objective: To determine the significance of myeloid-based expression of MKP-1 in oral cancer. Immunopeptidomics:Article Title: MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension. Article Snippet: Mitogen-activated protein kinases (MAPKs) require MAPK phosphatases (MKPs) for deactivation of MAPK intracellular signaling.. MKP-1 (encoded by Dusp1) is a key negative regulator of MAPKs and prior reports have indicated that MKP-1 regulates oral cancer-associated inflammation and leukocyte infiltration.. Objective: To determine the significance of myeloid-based expression of MKP-1 in oral cancer. other:Article Title: Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study. Article Snippet: Following incubationwith surface stain antibodies, cellswerewashed2 times with PBS and resuspended in 100uL of 4% cytofix/cytoperm (Cat: 554714, BD Biosciences) solution for 15min at RT in the dark. |